Psychedelics as Medicine 2025 - From Mind to Market:The Business of Psychedelics in a Changing World скачать в хорошем качестве

Psychedelics as Medicine 2025 - From Mind to Market:The Business of Psychedelics in a Changing World

From Mind to Market: The Business of Psychedelics in a Changing World explores the psychedelic industry and the business behind it. Featuring panelists Simeon Schnapper, Bismark Dadzie and Joel Brierre. Moderated by Krista Tippett. As the psychedelic industry grows, the balance between innovation, ethics, and accessibility becomes critical. This panel, featuring investors, entrepreneurs, and industry leaders will examine the business side of psychedelics—from venture capital and biotech developments to the challenges of commercializing psychedelic therapies while maintaining integrity and inclusivity. Simeon Schnapper is the Managing Partner at JLS Fund. As a psychedelic investor and general partner at JLS Fund, Schnapper has been supporting innovation in the psychedelic ecosystem for well over a decade. Bismark Dadzie is the Chief Operations Officer at ANP Farms Ltd Company, and a multifaceted professional bridging the worlds of agricultural entrepreneurship and progressive plant medicine research. Joel Brierre is the co-founder and CEO of FIVE, a training, research, and public education company dedicated to unlocking the full potential of 5-MeO-DMT, the world’s most powerful psychedelic. The moderator, Krista Tippett is the CEO/ Founder at On Being Project, a Peabody award-winning broadcaster, National Humanities Medalist, and New York Times bestselling author. Follow The Eden Foundation and Psychedelics Iceland @edenfoundation.co For more information on the Psychedelics as Medicine Conference www.psychedelicsiceland.com #Psychedelics #PsychedelicReasearch #PsychedelicsasMedicine #PsychedelicResearch #MentalHealth